Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06379113 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Name: GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients — clinical trial record (NCT06379113)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2/3

SponsorXiaojun Chen

Started2022-07-13

View on ClinicalTrials.gov ↗

To investigate the efficacy of GnRHa plus letrozole in obese progestin-insensitive EEC patients.

Amendment history 2 changes detected by DataLookout

2026-09-11

Primary completion pushed: 2026-03-30 → 2028-03-30

2026-09-11

Completion pushed: 2027-03-30 → 2028-03-30

Trial Details

NCT Number	NCT06379113
Lead Sponsor	Xiaojun Chen
Conditions	Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance, Obesity
Enrollment	29 participants
Start Date	2022-07-13
Primary Completion	2028-03-30 (estimated)
Study Completion	2028-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-09-10